The invention is directed to 11.beta.-aryl-17,17-spirothiolanesubstituted steroid compounds of formula (I) exhibiting binding tothe progestin receptor. ##STR1## Also disclosed are methods ofusing and process of making the compounds.
11.beta.-aryl-17, 17-spirothiolane-substituted steroids
Cook, C., Shetty, RS., Kepler, J., & Lee, DY. (2000). IPC No. U.S. 11.beta.-aryl-17, 17-spirothiolane-substituted steroids. (U.S. Patent No. 6043235).
Abstract
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.